Background
Methods
Study sites
Study type and population
Administration of the survey
Sample size estimation
Data management and analysis
Ethical consideration
Results
Characteristics of the study population
All women (n = 1030) | Term and delivery (n = 442) | |
---|---|---|
Age*
| ||
- Median [IQR] | 24 [20–29] | 26 [21–30] |
- <20 years, n(%) | 224 (21.8) | 80 (18.1) |
- 20–25 years, n (%) | 292 (28.4) | 123 (27.8) |
- >25 years, n (%) | 512 (49.8) | 239 (54.1) |
Primigravidae, n (%)
| 216 (21.0) | 85 (19.2) |
Bednet use, n (%)
| 608 (59.0) | 261 (59.0) |
IPTp-SP, n (%)
| 830 (80.6) | 372 (84.1) |
IPTp-SP 1
rst
dose, n (%)
| ||
1rst trimester | 49 (5.9) | |
2nd trimester | 658 (79.3) | |
3rd trimester | 123 (14.8) | |
First ANC visit, n (%)
| ||
1rst trimester | 225 (21.8) | |
2nd trimester | 766 (74.4) | |
3rd trimester | 39 (3.8) |
Antenatal care attendance
≤ 3 ANC visits (n = 126) | ≥ 4 ANC visits (n = 316) | |
---|---|---|
Age in years, median [IQR]
| 24 [20–29] | 26 [21–30] |
- <20 years, n(%) | 29 (23.0) | 51 (16.1) |
- 20–25 years, n (%) | 43 (34.1) | 80 (25.3) |
- >25 years, n (%) | 54 (42.9) | 185 (58.6) |
Primigravidae, n (%)
| 17 (13.5) | 68 (21.5) |
Multigravidae, n (%)
| 109 (86.5) | 248 (78.5) |
Education status, n (%)
| ||
- None | 1 (0.8) | 17 (5.3) |
- Primary school | 21 (16.7) | 41 (13.0) |
- Secondary school | 97 (77.0) | 210 (66.5) |
- High school | 7 (5.5) | 48 (15.2) |
Marital status, n (%)
| ||
- Single | 5 (4.0) | 38 (12.0) |
- Married | 121 (96.0) | 278 (88.0) |
IPTp-SP, n (%)
| 104 (82.5) | 268 (84.8) |
1 dose IPTp-SP, n (%)
| 49 (47.1) | 69 (25.7) |
≥2 doses IPTp-SP, n (%)
| 55 (52.9) | 199 (74.3) |
Bed net use, n (%)
| 82 (65.1) | 179 (56.6) |
ANC attendance and IPTp-SP and bed net use
Number of antenatal visits | ||||||
---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | ≥6 | |
n = 15 | n = 27 | n = 84 | n = 146 | n = 95 | n = 75 | |
SP doses without bed net use, n (%)
| ||||||
0 | 4 (26.7) | 4 (14.8) | 2 (2.4) | 11 (7.5) | 9 (9.5) | 7 (9.3) |
1 | 2 (13.3) | 2 (7.4) | 9 (10.7) | 13 (8.9) | 9 (9.5) | 10 (13.4) |
2 | 0 (0.0) | 3 (11.1) | 18 (21.4) | 31 (21.2) | 23 (24.2) | 20 (26.7) |
3 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 3 (2.1) | 0 (0.0) | 1 (1.3) |
0 or 1 SP dose + bed net use
| ||||||
n, (%) | 9 (60.0) | 8 (29.7) | 31 (36.9) | 34 (23.3) | 17 (17.8) | 7 (9.3) |
≥2 SP doses + bed net use (correct prevention)
| ||||||
n, (%) | 0 (0.0) | 10 (37.0) | 24 (28.6) | 54 (37.0) | 37 (39.0) | 30 (40.0) |